Moderate glaucoma best served by aggressive IOP-lowering efforts

London-The Early Manifest Glaucoma Trial (EMGT) provides a unique set of data for the natural history of moderate glaucoma and demonstrates that lowering IOP by 25% protects against progression of visual field loss, according to Roger A. Hitchings, MD.

Related Videos

Related Content

Endogena Therapeutics receives FDA fast track designation for retinitis pigmentosa treatment

February 7th 2023

Commercial real estate and your practice, part two with Colin Carr

May 21st 2022

CLOSE study offers updated surgical classification for treating large full-thickness macular holes

February 6th 2023

Tips, tricks, what to dos and what not to dos on how you can save money as a healthcare provider on your commercial real estate (Part 1)

May 12th 2022

Smart contact lens that diagnoses and treats glaucoma

February 5th 2023

Glaucoma 360: Hypotension and glaucoma progression

February 4th 2023

Endogena Therapeutics receives FDA fast track designation for retinitis pigmentosa treatment

February 7th 2023

Commercial real estate and your practice, part two with Colin Carr

May 21st 2022

CLOSE study offers updated surgical classification for treating large full-thickness macular holes

February 6th 2023

Tips, tricks, what to dos and what not to dos on how you can save money as a healthcare provider on your commercial real estate (Part 1)

May 12th 2022

Smart contact lens that diagnoses and treats glaucoma

February 5th 2023

Glaucoma 360: Hypotension and glaucoma progression

February 4th 2023

Endogena Therapeutics receives FDA fast track designation for retinitis pigmentosa treatment

February 7th 2023

Commercial real estate and your practice, part two with Colin Carr

May 21st 2022

CLOSE study offers updated surgical classification for treating large full-thickness macular holes

February 6th 2023

Tips, tricks, what to dos and what not to dos on how you can save money as a healthcare provider on your commercial real estate (Part 1)

May 12th 2022

Smart contact lens that diagnoses and treats glaucoma

February 5th 2023

Glaucoma 360: Hypotension and glaucoma progression

February 4th 2023

Related Content

---

Endogena Therapeutics receives FDA fast track designation for retinitis pigmentosa treatment

Article

---

Commercial real estate and your practice, part two with Colin Carr

Podcast

---

CLOSE study offers updated surgical classification for treating large full-thickness macular holes

Article

---

Tips, tricks, what to dos and what not to dos on how you can save money as a healthcare provider on your commercial real estate (Part 1)

Podcast

---

Smart contact lens that diagnoses and treats glaucoma

Article

---

Glaucoma 360: Hypotension and glaucoma progression

Article